Results 311 to 320 of about 11,948,174 (351)

EXPLOSIVE OUTBREAK OF AN ATYPICAL PNEUMONIA ("K-8 FEVER")

Archives of Internal Medicine, 1952
SEVERE sporadic "viral" pneumonias have been cited as often giving rise to diagnostic and therapeutic problems. 1 During recent years previously unidentified diseases have been found to present themselves as pneumonia of an "atypical" nature. The advent of newer antibiotics to which some of these diseases readily respond has accentuated the importance ...
openaire   +2 more sources

Ultrastructure and Viability of K. pneumoniae Treated with Fosfomycin

Zentralblatt für Bakteriologie. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie, 1980
The effect of Fosfomycin on K. pneumoniae ATCC 10031 was studied. The morphology on the electron microscopical level and the viability were markedly altered after application of 6 micrograms/ml and 60 micrograms/ml of Fosfomycin, respectively. These were chosen because they can be attained in man by oral or parenteral administration. Until 30 min after
openaire   +2 more sources

MRP8/14 is a Protective Mediator in Murine Klebsiella (K.) Pneumoniae Induced Pneumonia

Annals of Paediatric Rheumatology, 2012
BACKGROUND: K. pneumoniae is a common cause of pneumonia-derived sepsis. MRP8 and MRP14 are the most abundant cytoplasmic proteins in neutrophils. They can form MRP8/14 heterodimers that are released during invasive infectious diseases. MRP8/14 reportedly exerts antimicrobial activity and enhances the pro-inflammatory response via Toll-like receptor ...
Ahmed Achouiti, Thomas Vogl, Constantin Urban, Tijmen Hommes, Marieke Zoelen, Sandrine Florquin, Johannes Roth, Cornelis van, t Veer, Alex Vos, Tom Poll   +10 more
openaire   +1 more source

In vitro activity of minocycline combined with aminoglycosides against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae

The Journal of Antibiotics, 2018
This study assessed the in vitro antibacterial activity of minocycline-aminoglycoside combination against Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. Seventy non-duplicate clinical isolates of KPC-producing K. pneumoniae were collected from patients with bloodstream infections.
Ni, Wentao, Li, Guobao, Zhao, Jin, Cui, Junchang, Wang, Rui, Gao, Zhancheng, Liu, Youning   +6 more
openaire   +2 more sources

K. pneumoniae MGH 78578 Annotation

Genome ...
openaire   +1 more source

Effect of a Metalloantibiotic Produced by Pseudomonas aeruginosa on Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae

Current Pharmaceutical Biotechnology, 2016
Multidrug-resistant organisms (MDRO) are a great problem in hospitals, where thousands of people are infected daily, with the occurrence of high mortality rates, especially in infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-producing Kpn).
Gilselena, Kerbauy, Ana C P, Vivan, Glenda C, Simões, Ane S, Simionato, Marsileni, Pelisson, Eliana C, Vespero, Silvia F, Costa, Celia G T de J, Andrade, Daiane M, Barbieri, João C P, Mello, Alexandre T, Morey, Lucy M, Yamauchi, Sueli F, Yamada-Ogatta, Admilton G, de Oliveira, Galdino, Andrade   +14 more
openaire   +2 more sources

K-Mer Fingerprinting with RNN to predict MICs for K. pneumoniae

2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), 2022
Cory Kromer-Edwards, Mariana Castanheira, Suely Oliveira   +2 more
openaire   +1 more source

Pouvoir vaccinant de ribosomes extraits de K. Pneumoniae, D. Pneumoniae, S. Pyogenes, H. Influenzae et d'une fraction membranaire de K. Pneumoniae

Revue Française d'Allergologie et d'Immunologie Clinique, 1977
R. Fontanges, D. Robert, Y. Content, G. Nis   +3 more
openaire   +1 more source

preprint about K. pneumonia

2020
openaire   +1 more source

Population genomics of Klebsiella pneumoniae

Nature Reviews Microbiology, 2020
Kelly L Wyres, Kat Holt
exaly